Edition:
United Kingdom

Halozyme Therapeutics Inc (HALO.OQ)

HALO.OQ on NASDAQ Stock Exchange Global Select Market

17.85USD
18 Jan 2018
Change (% chg)

$-0.13 (-0.72%)
Prev Close
$17.98
Open
$17.65
Day's High
$18.00
Day's Low
$17.57
Volume
354,423
Avg. Vol
423,553
52-wk High
$21.12
52-wk Low
$10.75

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 19 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 4 4
(3) HOLD 3 3 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.30 2.30 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5 38.56 44.40 34.00 --
Quarter Ending Jun-18 5 40.89 46.40 35.00 --
Year Ending Dec-18 9 175.06 206.00 144.09 184.54
Earnings (per share)
Quarter Ending Mar-18 6 -0.18 -0.13 -0.25 --
Quarter Ending Jun-18 6 -0.17 -0.11 -0.26 --
Year Ending Dec-18 10 -0.67 -0.24 -1.07 -0.80
LT Growth Rate (%) 1 55.00 55.00 55.00 48.97

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 58.95 63.73 4.78 8.11
Quarter Ending Jun-17 31.76 33.75 1.99 6.27
Quarter Ending Mar-17 30.85 29.57 1.29 4.17
Quarter Ending Dec-16 38.37 39.00 0.63 1.65
Quarter Ending Sep-16 33.86 31.85 2.00 5.92
Earnings (per share)
Quarter Ending Sep-17 -0.10 0.02 0.12 -120.60
Quarter Ending Jun-17 -0.24 -0.23 0.01 -4.96
Quarter Ending Mar-17 -0.25 -0.26 0.01 -5.69
Quarter Ending Dec-16 -0.28 -0.21 0.07 -24.70
Quarter Ending Sep-16 -0.27 -0.23 0.04 -13.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 38.56 38.56 38.56 38.56 --
Quarter Ending Jun-18 40.89 40.89 40.89 40.89 --
Year Ending Dec-18 175.06 177.43 179.68 173.86 184.54
Earnings (per share)
Quarter Ending Mar-18 -0.18 -0.17 -0.17 -0.18 --
Quarter Ending Jun-18 -0.17 -0.17 -0.17 -0.18 --
Year Ending Dec-18 -0.67 -0.64 -0.62 -0.68 -0.80

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 1 0 2
Earnings
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 1 1 1 2